John E. Gallina's Insider Trades & SAST Disclosures
John E. Gallina's most recent trade in Elevance Health Inc was a trade of 11,782 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John E. Gallina.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 11,782 | 11,782 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 9,716 | 68,375 (0%) | 0% | 0 | Common Stock | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 4,650 | 63,725 (0%) | 0% | 468.8 | 2,179,827 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,065 | 58,659 (0%) | 0% | 0 | Common Stock | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 587 | 55,594 (0%) | 0% | 469.0 | 275,321 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,594 | 11,594 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,250 | 58,014 (0%) | 0% | 0 | Common Stock | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 4,162 | 46,857 (0%) | 0% | 451.5 | 1,879,143 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,907 | 49,764 (0%) | 0% | 0 | Common Stock | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Mar 2022 | 1,420 | 56,181 (0%) | 0% | 0 | Common Stock | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.49 per share. | 01 Mar 2022 | 413 | 57,601 (0%) | 0% | 463.5 | 191,421 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 19,908 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 24 May 2021 | 19,908 | 86,003 (0%) | 0% | 167.0 | 3,324,039 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 393.56 per share. | 24 May 2021 | 17,819 | 82,945 (0%) | 0% | 393.6 | 7,012,846 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 395.67 per share. | 24 May 2021 | 15,262 | 59,520 (0%) | 0% | 395.7 | 6,038,716 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 14,761 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 24 May 2021 | 14,761 | 100,764 (0%) | 0% | 232.0 | 3,425,142 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 394.62 per share. | 24 May 2021 | 8,163 | 74,782 (0%) | 0% | 394.6 | 3,221,283 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.93 per share. | 24 May 2021 | 5,775 | 60,095 (0%) | 0% | 146.9 | 848,521 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 5,775 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 397.91 per share. | 24 May 2021 | 4,100 | 54,320 (0%) | 0% | 397.9 | 1,631,431 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 4,038 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.51 per share. | 24 May 2021 | 4,038 | 66,095 (0%) | 0% | 132.5 | 535,075 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 24 May 2021 | 3,301 | 51,019 (0%) | 0% | 0 | Common Stock | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 1,962 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.80 per share. | 24 May 2021 | 1,962 | 62,057 (0%) | 0% | 131.8 | 258,592 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 396.50 per share. | 24 May 2021 | 1,100 | 58,420 (0%) | 0% | 396.5 | 436,150 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 23,222 | 54,803 (0%) | 0% | 0 | Common Stock | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 12,357 | 12,357 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 10,633 | 28,571 (0%) | 0% | 311.5 | 3,311,967 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 3,010 | 31,581 (0%) | 0% | 0 | Common Stock | |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 483 | 54,320 (0%) | 0% | 311.7 | 150,532 | Common Stock |
| Elevance Health Inc | John E. Gallina | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2020 | 2,589 | 39,204 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges